Company / FCF Margin
Edesa Biotech, Inc. FCF Margin History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1518.0%
FY2021
5-year range
-2191.3% / -617.8%
FY2017-FY2021
Trend
-28.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 7 years, ranging from -2191.3% in FY2018 to -514.3% in FY2015.
Based on SEC 10-K filings.
-1518.0% in FY2021 with a 5-year CAGR of -296.4%.
Improved from -2191.3% to -1518.0% over the past 3 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +673.3pp
- 5-Year Change
- -296.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2021, fcf margin decreased 28.5% year-over-year.
- Peak fcf margin was recorded in FY2015.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -1518.0% | -28.5% |
| FY2020 | -1181.4% | +46.1% |
| FY2018 | -2191.3% | -254.7% |
| FY2017 | -617.8% | +49.4% |
| FY2016 | -1221.5% | -137.5% |
| FY2015 | -514.3% | +63.5% |
| FY2014 | -1407.5% | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026